milrinone has been researched along with enoximone in 55 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 28 (50.91) | 18.7374 |
1990's | 18 (32.73) | 18.2507 |
2000's | 6 (10.91) | 29.6817 |
2010's | 3 (5.45) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barney, CL; Burkhard, T; Ertel, MA; Kariya, T; Kastner, PR; Marshall, FN; Matthews, DP; McCarthy, JR; Shea, PJ; Whitten, JP | 1 |
Bobowski, G; Bristol, JA; Burke, SE; Evans, DB; Newton, RS; Sircar, I; Steffen, RP; Weishaar, RE | 1 |
Bristol, JA; Humblet, CC; McPhail, AT; Moos, WH; Rithner, C; Sircar, I; Weishaar, RE | 1 |
Bagli, J; Bogri, T; Lee, DK; McQuillan, J; Palameta, B; Peseckis, S; Rakhit, S | 1 |
Alabaster, CT; Bell, AS; Campbell, SF; Ellis, P; Henderson, CG; Roberts, DA; Ruddock, KS; Samuels, GM; Stefaniak, MH | 1 |
Bobowski, G; Bristol, JA; Duell, BL; Evans, DB; Sircar, I | 1 |
Erhardt, PW | 1 |
Alvarez, R; Bruno, JJ; Jones, GH; Venuti, MC | 1 |
Hayes, JS; Kauffman, RF; Krushinski, JH; Pollock, GD; Robertson, DW; Wilson, H | 1 |
Cantor, E; Chou, YL; Erhardt, PW; Hagedorn, AA; Ingebretsen, WR; Lampe, JW; Lumma, WC; Pang, D; Pease, CA; Wohl, RA | 1 |
Bristol, JA; Evans, DB; Moos, WH; Sircar, I; Weishaar, RE | 1 |
Topliss, JG; Yoshida, F | 1 |
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
England, PJ; Murray, KJ | 1 |
D'Aubioul, JA; de Chaffoy de Courcelles, DR; De Clerck, FF; Hermans, CF; Vandeplassche, GM; Wouters, LJ | 1 |
Boldt, J; Hempelmann, G; Knothe, C | 1 |
Fahrenkrog, U; Löllgen, H | 1 |
Holmberg, SR; Williams, AJ | 1 |
Lehot, JJ | 1 |
Abdel-Aleem, S; Badr, M; Frangakis, C | 1 |
Abdel-aleem, S; Frangakis, C | 1 |
Drexler, H; Löllgen, H | 1 |
Blinks, JR; Endoh, M; Taira, N; Yanagisawa, T | 1 |
Braunwald, E; Colucci, WS; Wright, RF | 1 |
Ahn, HS; Eardley, D; Prioli, N; Watkins, R | 1 |
Keren, G; LeJemtel, TH; Reis, D; Sonnenblick, EH | 1 |
Baim, DS | 2 |
Hood, WB | 1 |
Hess, ML; Wood, MA | 1 |
Janicki, JS; Maskin, CS; Weber, KT | 1 |
Andersson, KE | 1 |
Dhainaut, JF | 1 |
Chiotti, D; Presbitero, P | 1 |
Leier, CV | 1 |
Chatterjee, K; Daly, PA; Kereiakes, D; Modin, G; Simonton, CA | 1 |
Beavo, JA; Chang, ML; Harrison, SA | 1 |
Tommaso, CL | 1 |
Beavo, JA; Cadd, GG; Gallis, B; Harrison, SA; Reifsnyder, DH | 1 |
Carlier, J; D'Orio, V; el Allaf, D | 1 |
Arbogast, R | 1 |
Lindeborg, DM; Pearl, RG | 1 |
de Chaffoy de Courcelles, D; Roevens, P | 1 |
Levy, JH; Salmenperä, M | 1 |
Bristow, MR; Eki, Y; Focaccio, A; Krall, J; Movsesian, M; Peeters, G; Roden, R | 1 |
Pfaffendorf, M; van Wezel, HB; van Zwieten, PA; Vroom, MB | 1 |
Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
Graf, BM; Grube, C; Martin, E; Stowe, DF; Zausig, YA; Zink, W | 1 |
Calabrò, MG; Covello, RD; Greco, M; Greco, T; Landoni, G; Morelli, A; Pasin, L; Zangrillo, A | 1 |
Bartsota, M; Bentley, S; Furck, AK; Rigby, ML; Slavik, Z | 1 |
Beute, J; Boon, L; Braunstahl, GJ; de Bruijn, MJ; Ganesh, K; Hendriks, RW; Hockman, S; KleinJan, A; Koekoek, EP; Lambrecht, BN; Lukkes, M; Manganiello, VC; Nastiti, H; van Nimwegen, M | 1 |
18 review(s) available for milrinone and enoximone
Article | Year |
---|---|
In search of the digitalis replacement.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Cyclic AMP; Digitalis Glycosides; Heart Failure; Humans; Myocardial Contraction; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1987 |
Inhibitors of cyclic nucleotide phosphodiesterases as therapeutic agents.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Benzimidazoles; Dihydropyridines; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoenzymes; Milrinone; Oxindoles; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Vasodilator Agents | 1992 |
[Treatment with phosphodiesterase inhibitors: Pro].
Topics: Cardiac Output, Low; Enoximone; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1992 |
[Treatment with phosphodiesterase inhibitors: Contra].
Topics: Cardiac Output, Low; Enoximone; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1992 |
Use of inotropes in the critical care setting.
Topics: Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Epinephrine; Humans; Imidazoles; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stimulation, Chemical | 1990 |
New positive inotropic agents in the treatment of congestive heart failure. Mechanisms of action and recent clinical developments. 2.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Administration, Oral; Aminopyridines; Amrinone; Cardiotonic Agents; Coenzymes; Enoximone; Heart; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Nifedipine; Oxyfedrine; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Quinazolines; Ubiquinone | 1986 |
The role of novel inotropic agents in the treatment of heart failure.
Topics: Amrinone; Animals; Cardiotonic Agents; Dobutamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Physical Exertion; Pyridazines; Pyridones; Time Factors | 1986 |
Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine.
Topics: Clinical Trials as Topic; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1989 |
Long-term oral therapy of congestive heart failure with phosphodiesterase inhibitors.
Topics: Administration, Oral; Amrinone; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1989 |
Effects of new inotropic agents on exercise performance.
Topics: Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiac Output; Cardiotonic Agents; Chronic Disease; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Muscles; Oxygen; Oxygen Consumption; Physical Exertion; Pulmonary Wedge Pressure; Pyridones; Time Factors | 1986 |
Some new positive inotropic agents.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Aminopyridines; Amrinone; Cardiotonic Agents; Dobutamine; Dopamine; Drug Tolerance; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Practolol; Prenalterol; Pyridones | 1986 |
[New inotropic drugs].
Topics: Adrenergic beta-Agonists; Amrinone; Cardiotonic Agents; Deoxyepinephrine; Enoximone; Ethanolamines; Heart; Humans; Imidazoles; Milrinone; Myocardial Contraction; Propanolamines; Pyridazines; Pyridones; Vasodilator Agents; Xamoterol | 1988 |
Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
Topics: Administration, Oral; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Physical Exertion; Pyridones; Thrombocytopenia; Time Factors | 1986 |
The new inotropic phosphodiesterase inhibitors.
Topics: Aminopyridines; Amrinone; Calcium; Carbamates; Cardiotonic Agents; Cardiovascular Agents; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridones; Quinazolines; Stimulation, Chemical; Time Factors; Xanthines | 1984 |
[Effects of phosphodiesterase inhibitors on diastolic function].
Topics: Diastole; Enoximone; Heart Diseases; Humans; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1993 |
Inotropic therapy in the critically ill patient.
Topics: Amrinone; Cardiac Glycosides; Cardiotonic Agents; Catecholamines; Critical Illness; Enoximone; Humans; Milrinone; Pyridones | 1993 |
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
A Bayesian network meta-analysis on the effect of inodilatory agents on mortality.
Topics: Bayes Theorem; Cardiac Surgical Procedures; Critical Illness; Dobutamine; Enoximone; Humans; Hydrazones; Milrinone; Pyridazines; Simendan; Vasodilator Agents | 2015 |
1 trial(s) available for milrinone and enoximone
Article | Year |
---|---|
Controlled and uncontrolled studies of phosphodiesterase III inhibitors in contemporary cardiovascular medicine.
Topics: Clinical Trials as Topic; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones | 1989 |
37 other study(ies) available for milrinone and enoximone
Article | Year |
---|---|
Synthesis and cardiotonic activity of novel biimidazoles.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Amrinone; Animals; Blood Pressure; Cardiotonic Agents; Chemical Phenomena; Chemistry; Dogs; Furans; Heart Rate; Imidazoles; Isoenzymes; Milrinone; Molecular Structure; Myocardial Contraction; Pyridones; Rats; Stimulation, Chemical; Structure-Activity Relationship; Thiazoles; Thiophenes | 1990 |
Cardiotonic agents. 9. Synthesis and biological evaluation of a series of (E)-4,5-dihydro-6-[2-[4-(1H-imidazol-1-yl)phenyl]ethenyl]-3 (2H)-pyridazinones: a novel class of compounds with positive inotropic, antithrombotic, and vasodilatory activities for t
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Cardiotonic Agents; Dogs; Female; Fibrinolytic Agents; Heart Failure; Humans; Imidazoles; Male; Myocardial Contraction; Platelet Aggregation; Pyridazines; Structure-Activity Relationship; Vasodilator Agents | 1989 |
Cardiotonic agents. 8. Selective inhibitors of adenosine 3',5'-cyclic phosphate phosphodiesterase III. Elaboration of a five-point model for positive inotropic activity.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Cardiotonic Agents; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Myocardial Contraction; Spectrophotometry, Infrared; X-Ray Diffraction | 1987 |
Chemistry and positive inotropic effect of pelrinone and related derivatives. A novel class of 2-methylpyrimidones as inotropic agents.
Topics: Animals; Blood Pressure; Cats; Dogs; Heart Rate; Models, Molecular; Myocardial Contraction; Pyrimidines; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical; Structure-Activity Relationship | 1988 |
2(1H)-quinolinones with cardiac stimulant activity. 1. Synthesis and biological activities of (six-membered heteroaryl)-substituted derivatives.
Topics: Animals; Dogs; Heart; Myocardial Contraction; Quinolones; Stimulation, Chemical; Structure-Activity Relationship | 1988 |
Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents.
Topics: Adrenergic beta-Antagonists; Animals; Cardiotonic Agents; Chemical Phenomena; Chemistry, Physical; Dogs; Heart Failure; Imidazoles; Myocardial Contraction; Pyridazines; Structure-Activity Relationship | 1985 |
Inhibitors of cyclic AMP phosphodiesterase. 2. Structural variations of N-cyclohexyl-N-methyl-4-[(1,2,3,5-tetrahydro- 2-oxoimidazo[2,1-b]quinazolin-7-yl)-oxy]butyramide (RS-82856).
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Platelets; Dogs; Humans; Imidazoles; Indicators and Reagents; Magnetic Resonance Spectroscopy; Mass Spectrometry; Myocardium; Quinazolines; Quinolines; Rats; Spectrophotometry, Infrared; Structure-Activity Relationship | 1987 |
Dihydropyridazinone cardiotonics: synthesis and inotropic activity of 5'-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)spiro[cycloalkane- 1,3'-[3H]indol]-2'(1'H)-ones.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Chemical Phenomena; Chemistry; Dogs; Female; Indoles; Isoenzymes; Male; Myocardial Contraction; Myocardium; Pyridazines; Sarcoplasmic Reticulum; Spiro Compounds; Stimulation, Chemical; Structure-Activity Relationship | 1987 |
Cardiotonic agents. 2. (Imidazolyl)aroylimidazolones, highly potent and selective positive inotropic agents.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Pressure; Chemical Phenomena; Chemistry; Ferrets; Heart Rate; Imidazoles; Myocardial Contraction; Papillary Muscles; Stimulation, Chemical; Structure-Activity Relationship | 1987 |
Cardiotonic agents. 1. 4,5-Dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3 (2H)-pyridazinones: novel positive inotropic agents for the treatment of congestive heart failure.
Topics: Animals; Cardiotonic Agents; Dogs; Guinea Pigs; Heart Failure; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines | 1984 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Comparative effects of R 80122, enoximone, and milrinone on left ventricular phosphodiesterase isoenzymes in vitro and on contractility of normal and stunned myocardium in vivo in dogs.
Topics: Analysis of Variance; Animals; Cardiotonic Agents; Dogs; Enoximone; Female; Heart Ventricles; Hemodynamics; Imidazoles; In Vitro Techniques; Isoenzymes; Male; Milrinone; Myocardial Contraction; Myocardial Reperfusion; Myocardium; Phosphodiesterase Inhibitors; Phosphoric Diester Hydrolases; Pyridones; Quinazolines | 1992 |
Phosphodiesterase inhibitors and the cardiac sarcoplasmic reticulum calcium release channel: differential effects of milrinone and enoximone.
Topics: Animals; Calcium Channels; Dose-Response Relationship, Drug; Enoximone; Imidazoles; In Vitro Techniques; Ion Channel Gating; Milrinone; Myocardium; Phosphodiesterase Inhibitors; Pyridones; Ryanodine; Sarcoplasmic Reticulum; Sheep | 1991 |
[New positive inotropic drugs].
Topics: Adrenergic Agonists; Amrinone; Cardiotonic Agents; Dopamine; Enoximone; Hemodynamics; Humans; Imidazoles; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Pyridazines; Pyridones; Shock, Cardiogenic | 1991 |
Stimulation of fatty acid oxidation in myocytes by phosphodiesterase inhibitors and adenosine analogues.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine; Amrinone; Animals; Cells, Cultured; Dipyridamole; Enoximone; Heart; Imidazoles; Milrinone; Myocardium; Oxidation-Reduction; Palmitic Acid; Palmitic Acids; Phosphodiesterase Inhibitors; Purinones; Pyridazines; Pyridones; Rats | 1991 |
Stimulation of fatty acid oxidation by phosphodiesterase III inhibitors in rat myocytes.
Topics: Animals; Cells, Cultured; Enoximone; Heart; Imidazoles; Male; Milrinone; Muscle, Smooth, Vascular; Oxidation-Reduction; Palmitates; Phosphodiesterase Inhibitors; Pyridones; Rats; Rats, Inbred Strains | 1991 |
Enoximone and milrinone--inotropic vasodilators for severe heart failure.
Topics: Cardiotonic Agents; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Pyridones | 1991 |
Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Aequorin; Aminopyridines; Amrinone; Animals; Calcium; Carbachol; Cardiotonic Agents; Colforsin; Cyclic AMP; Dogs; Dose-Response Relationship, Drug; Enoximone; Female; Imidazoles; Male; Milrinone; Myocardial Contraction; Myocardium; Nifedipine; Nucleotides, Cyclic; Pyrazines; Pyridones; Quinolines; Time Factors | 1986 |
Effects of several newer cardiotonic drugs on cardiac cyclic AMP metabolism.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; 3',5'-Cyclic-GMP Phosphodiesterases; Adenylyl Cyclases; Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Colforsin; Cyclic AMP; Enoximone; Guinea Pigs; Hydrolysis; Imidazoles; Isoenzymes; Milrinone; Myocardial Contraction; Myocardium; Phosphodiesterase Inhibitors; Pyridones | 1986 |
Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow.
Topics: Amrinone; Animals; Coronary Circulation; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones | 1989 |
[Use of new inotropic agents in the treatment of acute cardiac failure].
Topics: Adrenergic Agonists; Amrinone; Calcium Channel Blockers; Cardiotonic Agents; Dobutamine; Dopamine; Enoximone; Heart Failure; Humans; Imidazoles; Milrinone; Myocardial Contraction; Pyridones | 1988 |
General overview and update of positive inotropic therapy.
Topics: Amrinone; Blood Pressure; Cardiotonic Agents; Digitoxin; Dobutamine; Dopamine; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Isoproterenol; Milrinone; Norepinephrine; Phosphodiesterase Inhibitors; Pyridones; Stroke Volume; Time Factors | 1986 |
Survival in severe left ventricular failure treated with the new nonglycosidic, nonsympathomimetic oral inotropic agents.
Topics: Administration, Oral; Aged; Anti-Arrhythmia Agents; Cardiotonic Agents; Death, Sudden; Drug Evaluation; Enoximone; Female; Heart Failure; Humans; Imidazoles; Male; Middle Aged; Milrinone; Pyridones; Quinazolines; Retrospective Studies; Time Factors | 1987 |
Differential inhibition of cardiac cyclic nucleotide phosphodiesterase isozymes by cardiotonic drugs.
Topics: Aminopyridines; Amrinone; Animals; Antibodies, Monoclonal; Cardiotonic Agents; Cattle; Cyclic GMP; Enoximone; Imidazoles; Isoenzymes; Mice; Milrinone; Myocardium; Nucleotides, Cyclic; Phosphodiesterase Inhibitors; Pyridones; Rabbits | 1986 |
Isolation and characterization of bovine cardiac muscle cGMP-inhibited phosphodiesterase: a receptor for new cardiotonic drugs.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminopyridines; Amrinone; Animals; Antibodies, Monoclonal; Cardiotonic Agents; Cattle; Chromatography, DEAE-Cellulose; Chromatography, High Pressure Liquid; Cyclic GMP; Enoximone; Imidazoles; Immune Sera; Kinetics; Mice; Mice, Inbred BALB C; Milrinone; Molecular Weight; Myocardium; Phosphodiesterase Inhibitors; Phosphorylation; Pyridones | 1986 |
Effects of amrinone on myocardial energetics in severe congestive heart failure.
Topics: Aminopyridines; Amrinone; Animals; Cardiotonic Agents; Coronary Circulation; Dogs; Enoximone; Heart; Heart Failure; Humans; Imidazoles; Isoproterenol; Milrinone; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Pyridones | 1985 |
Cyclic AMP-phosphodiesterase IIIA1 inhibitors decrease cytosolic Ca2+ concentration and increase the Ca2+ content of intracellular storage sites in human platelets.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Aminoquinolines; Blood Platelets; Calcium; Chlortetracycline; Cytosol; Enoximone; Heart; Homeostasis; Humans; Imidazoles; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Quinazolines | 1993 |
The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Amrinone; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Humans; Mammary Arteries; Milrinone; Norepinephrine; Papaverine; Phosphodiesterase Inhibitors; Prostaglandin Endoperoxides, Synthetic; Pyridones; Thromboxane A2; Vasoconstriction; Vasoconstrictor Agents; Vasodilator Agents | 1996 |
Mechanism of action of OPC-8490 in human ventricular myocardium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Action Potentials; Adult; Azetidines; Cardiotonic Agents; Cyclic Nucleotide Phosphodiesterases, Type 3; Enoximone; Heart; Heart Failure; Heart Ventricles; Humans; In Vitro Techniques; Ion Channels; Middle Aged; Milrinone; Myocardial Contraction; Phosphodiesterase Inhibitors; Piperazines; Pyridones; Quinolones; Sotalol; Ventricular Function; Veratridine | 1996 |
Effect of phosphodiesterase inhibitors on human arteries in vitro.
Topics: Adolescent; Adult; Amrinone; Analgesics; Anilides; Arginine; Arteries; Dipyridamole; Enoximone; Female; Glyburide; Humans; In Vitro Techniques; Middle Aged; Milrinone; Phosphodiesterase Inhibitors; Pyridones; Theophylline; Vasoconstriction; Vasodilation | 1996 |
A comparison of three phosphodiesterase type III inhibitors on mechanical and metabolic function in guinea pig isolated hearts.
Topics: Amrinone; Animals; Cardiotonic Agents; Coronary Circulation; Dose-Response Relationship, Drug; Enoximone; Guinea Pigs; Heart; Heart Rate; In Vitro Techniques; Milrinone; Myocardial Contraction; Myocardium; Oxygen Consumption; Phosphodiesterase Inhibitors; Vasodilation | 2006 |
Oral Enoximone as an Alternative to Protracted Intravenous Medication in Severe Pediatric Myocardial Failure.
Topics: Adrenergic beta-Antagonists; Cardiotonic Agents; Child; Enoximone; Heart Failure; Hemodynamics; Humans; Milrinone; Ventricular Dysfunction, Left | 2016 |
A pathophysiological role of PDE3 in allergic airway inflammation.
Topics: Allergens; Animals; Asthma; Biopsy; CD11b Antigen; Cells, Cultured; Cyclic Nucleotide Phosphodiesterases, Type 3; Disease Models, Animal; Enoximone; Eosinophils; Humans; Lung; Mice; Mice, Inbred C57BL; Mice, Knockout; Milrinone; Off-Label Use; Phosphodiesterase 3 Inhibitors; Primary Cell Culture; Pyroglyphidae; Up-Regulation | 2018 |